ES8602935A1 - Un vector reversible - Google Patents

Un vector reversible

Info

Publication number
ES8602935A1
ES8602935A1 ES525065A ES525065A ES8602935A1 ES 8602935 A1 ES8602935 A1 ES 8602935A1 ES 525065 A ES525065 A ES 525065A ES 525065 A ES525065 A ES 525065A ES 8602935 A1 ES8602935 A1 ES 8602935A1
Authority
ES
Spain
Prior art keywords
yeast
gene
hbsag
shuttle vector
prepn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525065A
Other languages
English (en)
Other versions
ES525065A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Publication of ES525065A0 publication Critical patent/ES525065A0/es
Publication of ES8602935A1 publication Critical patent/ES8602935A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE UN VECTOR REVERSIBLE LEVADURA E. COLI CON UN PROMOTOR DE FOSFATASA ACIDA REPRIMIBLE. CONSISTE EN COMBINAR 1 UN GEN DE LEVADURA QUE CONTIENE A) UN GEN, CON PROMOTOR INCLUIDO, DE FOSFATASA ACIDA, B) UNA SECUENCIA DE DNA NECESARIA PARA LA REPLICACION AUTONOMA DE LA LEVADURA C) UN GEN UTIL COMO MARCADOR SELECTIVO CON 2 EL PLASMIDO PBR322 DE E. COLI QUE CONTIENE A) UNA SECUENCIA DE DNA NECESARIA PARA LA REPLICACION DEL PLASMIDO DENTRO DE E. COLI B) UN GEN UTIL COMO MARCADOR SELECTIVO, PARA DAR LUGAR A UN PLASMIDO RECOMBINADO, EL CUAL, POR TRATAMIENTO CON UNA ENZIMA DE RESTRICCION, UNA EXONUCLEASA Y POSTERIORMENTE UNA LIGASA, CON ELIMINACION DE 1 A 50BP DEL GEN FOSFATASA ACIDA PERO NO SU PROMOTOR, SE OBTIENE UN VECTOR REVERSIBLE QUE PUEDE EXPRESAR UN GEN EXTRAÑO BAJO EL CONTROL DEL PROMOTOR DE FOSFATASA ACIDA.
ES525065A 1982-08-20 1983-08-19 Un vector reversible Expired ES8602935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57145093A JPS5936699A (ja) 1982-08-20 1982-08-20 シヤトルベクタ−

Publications (2)

Publication Number Publication Date
ES525065A0 ES525065A0 (es) 1985-12-01
ES8602935A1 true ES8602935A1 (es) 1985-12-01

Family

ID=15377210

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525065A Expired ES8602935A1 (es) 1982-08-20 1983-08-19 Un vector reversible

Country Status (8)

Country Link
US (1) US5707862A (es)
JP (2) JPS5936699A (es)
KR (1) KR840005740A (es)
AU (1) AU562633B2 (es)
CA (1) CA1270453A (es)
DK (1) DK381483A (es)
ES (1) ES8602935A1 (es)
SU (1) SU1393317A3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0811074B2 (ja) * 1987-10-30 1996-02-07 財団法人化学及血清療法研究所 プレアルブミンをコードする遺伝子を組込んだ組換えプラスミドおよびこれを用いたプレアルブミンの製法
JPH0291660U (es) * 1988-12-28 1990-07-20
EP1560919A2 (en) * 2001-03-29 2005-08-10 Genetic Technologies, L.P. Improved hybrid gene libraries and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2441659A1 (fr) * 1978-11-14 1980-06-13 Anvar Nouveaux plasmides hybrides et microorganismes les contenant
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency B型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
IL69202A (en) * 1982-09-08 1991-08-16 Smith Kline Rit Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
CA1341302C (en) * 1983-02-22 2001-10-09 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
JPH0655146B2 (ja) * 1985-12-27 1994-07-27 財団法人化学及血清療法研究所 シヤトルベクタ−

Also Published As

Publication number Publication date
JPS6155951B2 (es) 1986-11-29
DK381483A (da) 1984-02-21
CA1270453A (en) 1990-06-19
US5707862A (en) 1998-01-13
AU1800383A (en) 1984-02-23
ES525065A0 (es) 1985-12-01
JPH0665308B2 (ja) 1994-08-24
JPS5936699A (ja) 1984-02-28
SU1393317A3 (ru) 1988-04-30
JPS62115289A (ja) 1987-05-26
KR840005740A (ko) 1984-11-16
DK381483D0 (da) 1983-08-19
AU562633B2 (en) 1987-06-18

Similar Documents

Publication Publication Date Title
EP0101617A3 (en) Recombinant dna containing a hepatitis b virus gene, mammalian cells transformed with the cloned viral dna, and production of hepatitis b virus proteins
DE3280284D1 (de) Herstellung von oberflaechen-hepatitis-b-antigen in hefe.
ES8105388A1 (es) Un metodo para mantener, replicar y expresar por lo menos una porcion del genoma de un virus n.p.
ES8802162A1 (es) Un procedimiento para la preparacion de una levadura trans- formada con un plasmido recombinante insertado con el gen del virus de la hepatitis b.
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
PT77265A (en) Preparation of hepatitis b virus vaccine
EP0216564A3 (en) Infectious recombinant virus, vaccines containing said virus for feline leukemia, and methods for the production thereof
EP0105149A3 (en) Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen
ES8602935A1 (es) Un vector reversible
AU598181B2 (en) Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the receptor of polymerized human serum albumin, animal cells capable of producing such particles and method for the obtention thereof
Valenzuela et al. Hepatitis-B vaccine: Characterization of hepatitis-B antigen particles produced in yeast.
RU1651555C (ru) Рекомбинантна плазмидна ДНК р7,5С, кодирующа антиген вируса гепатита В, и способ ее конструировани
JPS6467191A (en) Recombinant dna plasmid having integrated hepatitis b virus gene, transformed animal cell, hepatitis b viral surface antigen protein and production thereof
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
NO306511B1 (no) Rekombinant vektor som selektivt hybridiserer til genomet av hepatitt C-virus (HCV), en vertscelle som er transformert med vektoren, og en fremgangsmaate for aa fremstille et terapeutisk aktivt polypeptid

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050919